ArticleCancers2018

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer.

Ahmed A Mostafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.